Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure
Phase 3
Completed
- Conditions
- Anemia
- First Posted Date
- 2006-11-14
- Last Posted Date
- 2009-06-11
- Lead Sponsor
- Cadila Pharnmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT00399269
- Locations
- 🇮🇳
Dr. Shishir Gang, Nadiad, Gujarat, India
© Copyright 2025. All Rights Reserved by MedPath